172 related articles for article (PubMed ID: 38301873)
1. G-quadruplex ligands in cancer therapy: Progress, challenges, and clinical perspectives.
Figueiredo J; Mergny JL; Cruz C
Life Sci; 2024 Mar; 340():122481. PubMed ID: 38301873
[TBL] [Abstract][Full Text] [Related]
2. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
3. Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy.
Asamitsu S; Obata S; Yu Z; Bando T; Sugiyama H
Molecules; 2019 Jan; 24(3):. PubMed ID: 30682877
[TBL] [Abstract][Full Text] [Related]
4. EMICORON: A multi-targeting G4 ligand with a promising preclinical profile.
Porru M; Zizza P; Franceschin M; Leonetti C; Biroccio A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1362-1370. PubMed ID: 27838395
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Biological Evaluation of New Substituted Diquinolinyl-Pyridine Ligands as Anticancer Agents by Targeting G-Quadruplex.
Das RN; Chevret E; Desplat V; Rubio S; Mergny JL; Guillon J
Molecules; 2017 Dec; 23(1):. PubMed ID: 29301210
[TBL] [Abstract][Full Text] [Related]
6. Metal-Organic Compounds as Anticancer Agents: Versatile Building Blocks for Selective Action on G-quadruplexes.
Toro PM; Saldias M; Valenzuela-Barra G
Curr Med Chem; 2023; 30(5):573-600. PubMed ID: 35670351
[TBL] [Abstract][Full Text] [Related]
7. Targeting G-Quadruplex DNA for Cancer Chemotherapy.
Debbarma S; Acharya PC
Curr Drug Discov Technol; 2022; 19(3):e140222201110. PubMed ID: 35156574
[TBL] [Abstract][Full Text] [Related]
8. Ligands stimulating antitumour immunity as the next G-quadruplex challenge.
Miglietta G; Marinello J; Russo M; Capranico G
Mol Cancer; 2022 Sep; 21(1):180. PubMed ID: 36114513
[TBL] [Abstract][Full Text] [Related]
9. Developing Novel G-Quadruplex Ligands: from Interaction with Nucleic Acids to Interfering with Nucleic Acid⁻Protein Interaction.
Sun ZY; Wang XN; Cheng SQ; Su XX; Ou TM
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678288
[TBL] [Abstract][Full Text] [Related]
10. G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting.
Romano F; Di Porzio A; Iaccarino N; Riccardi G; Di Lorenzo R; Laneri S; Pagano B; Amato J; Randazzo A
Expert Opin Ther Pat; 2023 Nov; 33(11):745-773. PubMed ID: 37855085
[TBL] [Abstract][Full Text] [Related]
11. Computational tools in the discovery of new G-quadruplex ligands with potential anticancer activity.
Castillo-González D; Pérez-Machado G; Pallardó F; Garrigues-Pelufo TM; Cabrera-Pérez MA
Curr Top Med Chem; 2012; 12(24):2843-56. PubMed ID: 23368106
[TBL] [Abstract][Full Text] [Related]
12. Design of Modular G-quadruplex Ligands.
Duarte AR; Cadoni E; Ressurreição AS; Moreira R; Paulo A
ChemMedChem; 2018 May; 13(9):869-893. PubMed ID: 29512884
[TBL] [Abstract][Full Text] [Related]
13. G-quadruplex, Friend or Foe: The Role of the G-quartet in Anticancer Strategies.
Carvalho J; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Trends Mol Med; 2020 Sep; 26(9):848-861. PubMed ID: 32467069
[TBL] [Abstract][Full Text] [Related]
14. Discovery of the first dual G-triplex/G-quadruplex stabilizing compound: a new opportunity in the targeting of G-rich DNA structures?
Amato J; Pagano A; Cosconati S; Amendola G; Fotticchia I; Iaccarino N; Marinello J; De Magis A; Capranico G; Novellino E; Pagano B; Randazzo A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1271-1280. PubMed ID: 27836755
[TBL] [Abstract][Full Text] [Related]
15. Metallo-organic G-quadruplex ligands in anticancer drug design.
Jiang YL; Liu ZP
Mini Rev Med Chem; 2010 Jul; 10(8):726-36. PubMed ID: 20412042
[TBL] [Abstract][Full Text] [Related]
16. Targeting of Telomeric Repeat-Containing RNA G-Quadruplexes: From Screening to Biophysical and Biological Characterization of a New Hit Compound.
Marzano S; Pagano B; Iaccarino N; Di Porzio A; De Tito S; Vertecchi E; Salvati E; Randazzo A; Amato J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638655
[TBL] [Abstract][Full Text] [Related]
17. DNA G-Quadruplex in Human Telomeres and Oncogene Promoters: Structures, Functions, and Small Molecule Targeting.
Chen L; Dickerhoff J; Sakai S; Yang D
Acc Chem Res; 2022 Sep; 55(18):2628-2646. PubMed ID: 36054116
[TBL] [Abstract][Full Text] [Related]
18. G-quadruplex ligands as potent regulators of lysosomes.
Ferret L; Alvarez-Valadez K; Rivière J; Muller A; Bohálová N; Yu L; Guittat L; Brázda V; Kroemer G; Mergny JL; Djavaheri-Mergny M
Autophagy; 2023 Jul; 19(7):1901-1915. PubMed ID: 36740766
[TBL] [Abstract][Full Text] [Related]
19. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
20. G-quadruplex in cancer biology and drug discovery.
Nakanishi C; Seimiya H
Biochem Biophys Res Commun; 2020 Oct; 531(1):45-50. PubMed ID: 32312519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
